Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.
Korfage
Ida J
IJ
D000728:Androgens / Q000172:deficiency; D006304:Health Status; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000009:adverse effects; D011471:Prostatic Neoplasms / Q000401:mortality / Q000503:physiopathology / Q000523:psychology* / Q000601:surgery*; D016032:Randomized Controlled Trials as Topic; D012537:Scandinavian and Nordic Countries; D016019:Survival Analysis; D017741:Survivors / Q000523:psychology
D000728:Androgens; D017430:Prostate-Specific Antigen